Magnetic nanoparticles (MNPs) have been extensively explored as magnetic resonance
imaging (MRI) contrast agents. With the increasing complexity in the structure of modern …

Ferrimagnetic iron oxide nanoparticles (magnetite or maghemite) have been the subject of
an intense research, not only for fundamental research but also for their potentiality in a …

Hollow‐structured nanomaterials (HSNMs) have attracted increased interest in biomedical
fields, owing to their excellent potential as drug delivery systems (DDSs) for clinical …

The accumulated knowledge of nanoparticle (NP) synthesis for the last 30 years has
enabled the development of functional NPs for biomedical applications. Especially, NPs with …

Great progress has been made in the preparation and application of multi-shelled hollow
micro-/nanostructures during the past decade. However, the synthetic methodologies and …

Iron oxide nanoparticle (IONP) with unique magnetic property and high biocompatibility
have been widely used as magnetic resonance imaging (MRI) contrast agent (CA) for long …

Recent advances in the development of magnetic nanoparticles (MNPs) have shown
promise in the development of new personalized therapeutic approaches for clinical …

Chemotherapy is still a main option for cancer therapy, but its efficacy is often unsatisfying
due to multidrug resistance (MDR). The tumor microenvironment is considered a dominant …

Sonodynamic therapy (SDT), as a novel non-invasive strategy for eliminating tumor, has the
advantages of deeper tissue penetration, fewer side effects, and better patient compliance …

To integrate real-time monitoring and therapeutic functions into a single nanoagent, we have
designed and synthesized a drug-delivery platform based on a polydopamine (PDA)/human …